In view of this, it was found that the Rho-associated protein kinase inhibitor AMA0825 reversed intestinal fibrosis in mice and decreased the release of pro-fibrotic markers in CD biopsies, such as matrix MMPs, collagen, and IL6 [100]. Here, IL6 is linked to Cowden disease.